These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19531008)

  • 41. Tools for GPCR drug discovery.
    Zhang R; Xie X
    Acta Pharmacol Sin; 2012 Mar; 33(3):372-84. PubMed ID: 22266728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplexed assays by high-content imaging for assessment of GPCR activity.
    Ross DA; Lee S; Reiser V; Xue J; Alves K; Vaidya S; Kreamer A; Mull R; Hudak E; Hare T; Detmers PA; Lingham R; Ferrer M; Strulovici B; Santini F
    J Biomol Screen; 2008 Jul; 13(6):449-55. PubMed ID: 18519922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-impedance-based label-free technology for the identification of new drugs.
    Lundstrom K
    Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
    van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The application of cell-based label-free technology in drug discovery.
    Xi B; Yu N; Wang X; Xu X; Abassi YA
    Biotechnol J; 2008 Apr; 3(4):484-95. PubMed ID: 18412175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-resolution metabolic profiling towards G protein-coupled receptors: rapid and comprehensive screening of histamine H₄ receptor ligands.
    Kool J; Rudebeck AF; Fleurbaaij F; Nijmeijer S; Falck D; Smits RA; Vischer HF; Leurs R; Niessen WM
    J Chromatogr A; 2012 Oct; 1259():213-20. PubMed ID: 22520160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a FLIPR assay for the simultaneous identification of MrgD agonists and antagonists from a single screen.
    Ajit SK; Pausch MH; Kennedy JD; Kaftan EJ
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20936132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Miniaturization of whole live cell-based GPCR assays using microdispensing and detection systems.
    Kornienko O; Lacson R; Kunapuli P; Schneeweis J; Hoffman I; Smith T; Alberts M; Inglese J; Strulovici B
    J Biomol Screen; 2004 Apr; 9(3):186-95. PubMed ID: 15140380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duplexed label-free G protein--coupled receptor assays for high-throughput screening.
    Tran E; Ye Fang
    J Biomol Screen; 2008 Dec; 13(10):975-85. PubMed ID: 19029014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mining the potential of label-free biosensors for seven-transmembrane receptor drug discovery.
    Rocheville M; Martin J; Jerman J; Kostenis E
    Prog Mol Biol Transl Sci; 2013; 115():123-42. PubMed ID: 23415093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. G protein-coupled receptor microarrays for drug discovery.
    Fang Y; Lahiri J; Picard L
    Drug Discov Today; 2004 Dec; 9(24 Suppl):S61-7. PubMed ID: 23573662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Label-free imaging and temporal signature in phenotypic cellular assays: a new approach to high-content screening.
    Martin J
    Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.13. PubMed ID: 22294376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview on Radiolabel-Free in vitro Assays for GPCRs.
    Buccioni M; Santinelli C; Angeli P; Dal Ben D; Lambertucci C; Thomas A; Volpini R; Marucci G
    Mini Rev Med Chem; 2017; 17(1):3-14. PubMed ID: 27515714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CellCard System: a novel approach to assessing compound selectivity for lead prioritization of G protein-coupled receptors.
    Beske O; Goldbard S; Turpin P
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):293-9. PubMed ID: 16101005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening.
    Gilchrist MA; Cacace A; Harden DG
    J Biomol Screen; 2008 Jul; 13(6):486-93. PubMed ID: 18566482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).
    Wang D; Li Y; Zhang Y; Liu Y; Shi G
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impedance-based cellular assay technologies: recent advances, future promise.
    McGuinness R
    Curr Opin Pharmacol; 2007 Oct; 7(5):535-40. PubMed ID: 17900985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular assays as portals to seven-transmembrane receptor-based drug discovery.
    Kenakin TP
    Nat Rev Drug Discov; 2009 Aug; 8(8):617-26. PubMed ID: 19609267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiplex GPCR assay in reverse transfection cell microarrays.
    Mishina YM; Wilson CJ; Bruett L; Smith JJ; Stoop-Myer C; Jong S; Amaral LP; Pedersen R; Lyman SK; Myer VE; Kreider BL; Thompson CM
    J Biomol Screen; 2004 Apr; 9(3):196-207. PubMed ID: 15140381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversible G Protein βγ9 Distribution-Based Assay Reveals Molecular Underpinnings in Subcellular, Single-Cell, and Multicellular GPCR and G Protein Activity.
    Senarath K; Ratnayake K; Siripurapu P; Payton JL; Karunarathne A
    Anal Chem; 2016 Dec; 88(23):11450-11459. PubMed ID: 27778511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.